Our Partners
OzUK has key industry partners to help you to clinic, scale-up and registration faster
Bespak is a global CDMO focused on inhaled and nasal drug delivery devices and drug-device combination products. With more than 60 years of experience in inhalation, Bespak develops and manufactures finished pharmaceutical products, as well as being a leading supplier of drug delivery devices and componentry to the pharmaceutical industry, supplying a major proportion of the world’s pMDI dosing valves and actuators. The company’s offering spans feasibility, analytical services and product development, pilot-scale through to clinical-scale and commercial-scale supply, as well as precision injection moulding and high speed automated assembly of critical components and devices. Bespak is leading the transition to pMDIs using low GWP propellants HFA-152a and HFO-1234ze. For more information go to: www.bespak.com
H&T Presspart is a renowned manufacturer and provider of high-quality components for respiratory drug delivery systems, including pMDIs. With over 50 years of experience in the industry, they have established themselves as a go-to source for precision-made components. H&T Presspart's expertise lies in the design and production of actuators, canisters, and other essential components for inhalation devices. Their commitment to innovation and quality ensures that their products enhance the efficiency and reliability of drug delivery, making them a preferred partner for pharmaceutical companies worldwide. H&T Presspart's dedication to advancing respiratory drug delivery technology underscores their pivotal role in the healthcare sector.
Ab Initio Pharma is an independent entity renowned for its expertise in the development of pMDI (pressurized metered-dose inhaler) products. Specializing in the early phases of pharmaceutical development, they offer a spectrum of services including formulation development, analytical testing, and regulatory support. With a keen focus on pMDI technology, Ab Initio Pharma leverages advanced methodologies and scientific acumen to navigate the complex landscape of inhaler product development. Their commitment to quality and efficiency ensures that clients' products not only adhere to the highest standards but also achieve a streamlined path to market. Ab Initio Pharma's role is pivotal for companies aiming to innovate and succeed in the respiratory drug delivery market.
